Alyssa advises public company clients across a broad range of industries regarding equity offerings, compliance with federal securities laws, and requirements of the major U.S. stock exchanges. She assists in-house counsel, management, and boards of directors on SEC and stock exchange disclosure and reporting requirements, director and executive compensation, and corporate governance matters.
Alyssa also counsels both public and private companies on the design, implementation and taxation of executive compensation and equity compensation arrangements, including executive employment agreements, change in control and severance plans, and cash and equity incentive programs, along with other compensation and benefits matters in the context of ongoing business operations, M&A transactions, spin-offs, and venture capital financings.
Alyssa advises public company clients across a broad range of industries regarding equity offerings, compliance with federal securities laws, and requirements of the major U.S. stock exchanges. She assists in-house counsel, management, and boards of directors on SEC and stock exchange disclosure and reporting requirements, director and executive compensation, and corporate governance matters.
Alyssa also counsels both public and private companies on the design, implementation and taxation of executive compensation and equity compensation arrangements, including executive employment agreements, change in control and severance plans, and cash and equity incentive programs, along with other compensation and benefits matters in the context of ongoing business operations, M&A transactions, spin-offs, and venture capital financings.
Chapin focuses on representing high-growth technology companies of all sizes throughout their life-cycles-- from general formation and corporate governance through to venture capital and private equity financings. He also advises investors and venture capital firms in their investments in early and high growth technology companies.
Chapin focuses on representing high-growth technology companies of all sizes throughout their life-cycles-- from general formation and corporate governance through to venture capital and private equity financings. He also advises investors and venture capital firms in their investments in early and high growth technology companies.
Jamie's practice focuses on domestic and cross-border mergers and acquisitions, advising companies on formation and equity financings, and corporate governance matters.
Jamie's practice focuses on domestic and cross-border mergers and acquisitions, advising companies on formation and equity financings, and corporate governance matters.
Clients turn to Eddie for strategic counsel on their most significant exposures. He has represented biopharmaceutical and molecular diagnostics companies in securities class actions and proxy contest disputes, advised global technology leaders and financial institutions in internal investigations and M&A-related disputes, and defended numerous clients in regulatory investigations. His experience also includes matters involving the Foreign Corrupt Practices Act (FCPA).
Eddie is frequently sought for his expertise in responding to investigations by the Department of Justice (DOJ), Securities and Exchange Commission (SEC), and other federal and state agencies, including self-regulatory organizations. He regularly guides audit and special committees through internal investigations related to SOX compliance, revenue recognition, and executive compensation, and defends clients in insider trading and securities fraud matters.
Recognized by Legal 500 for Securities Litigation: Defense and M&A Litigation: Defense and by Best Lawyers in America for Securities Litigation, Eddie is a regular speaker on securities litigation topics and has been quoted in leading periodicals. He has authored numerous articles on securities enforcement and litigation, sharing insights that reflect his deep understanding of the evolving securities litigation and regulatory landscape.
Clients turn to Eddie for strategic counsel on their most significant exposures. He has represented biopharmaceutical and molecular diagnostics companies in securities class actions and proxy contest disputes, advised global technology leaders and financial institutions in internal investigations and M&A-related disputes, and defended numerous clients in regulatory investigations. His experience also includes matters involving the Foreign Corrupt Practices Act (FCPA).
Eddie is frequently sought for his expertise in responding to investigations by the Department of Justice (DOJ), Securities and Exchange Commission (SEC), and other federal and state agencies, including self-regulatory organizations. He regularly guides audit and special committees through internal investigations related to SOX compliance, revenue recognition, and executive compensation, and defends clients in insider trading and securities fraud matters.
Recognized by Legal 500 for Securities Litigation: Defense and M&A Litigation: Defense and by Best Lawyers in America for Securities Litigation, Eddie is a regular speaker on securities litigation topics and has been quoted in leading periodicals. He has authored numerous articles on securities enforcement and litigation, sharing insights that reflect his deep understanding of the evolving securities litigation and regulatory landscape.
Alice advises boards of directors, issuers, underwriters and investors in a broad range of transactions, including public offerings; special purpose acquisition companies (SPACs); private placements of equity and debt securities, public mergers and acquisitions, and general corporate matters.
Alice also provides strategic advice on a myriad of securities regulation, corporate governance and other general corporate matters. She regularly counsels companies regarding Securities and Exchange Commission reporting and disclosure issues, stockholder meetings, proxy statements and proxy mechanics. Her work extends to advising public companies with respect to defensive review matters, including implementation of shareholders rights plans and related issues.
Alice advises boards of directors, issuers, underwriters and investors in a broad range of transactions, including public offerings; special purpose acquisition companies (SPACs); private placements of equity and debt securities, public mergers and acquisitions, and general corporate matters.
Alice also provides strategic advice on a myriad of securities regulation, corporate governance and other general corporate matters. She regularly counsels companies regarding Securities and Exchange Commission reporting and disclosure issues, stockholder meetings, proxy statements and proxy mechanics. Her work extends to advising public companies with respect to defensive review matters, including implementation of shareholders rights plans and related issues.
Julie represents early to late-stage companies as well as leading investors in venture capital financings, mergers and acquisitions, corporate formation and governance matters and ongoing corporate matters. She advises companies throughout their lifecycle and represents leading venture firms in connection with their investments in private companies, in all cases across industries.
Julie represents early to late-stage companies as well as leading investors in venture capital financings, mergers and acquisitions, corporate formation and governance matters and ongoing corporate matters. She advises companies throughout their lifecycle and represents leading venture firms in connection with their investments in private companies, in all cases across industries.
Please do not include any confidential, secret or otherwise sensitive information concerning any potential or actual legal matter in this e-mail message. Unsolicited e-mails do not create an attorney-client relationship and confidential or secret information included in such e-mails cannot be protected from disclosure. Orrick does not have a duty or a legal obligation to keep confidential any information that you provide to us. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.
By clicking "OK" below, you understand and agree that Orrick will have no duty to keep confidential any information you provide.